Zhangzhou Pientzehuang Pharmaceutical Co Ltd: A Snapshot of Recent Performance
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., a prominent player in the health care sector, has recently been in the spotlight due to its performance on the Shanghai Stock Exchange. As of June 17, 2025, the company’s close price stood at 200.12 CNH, reflecting a significant position within the pharmaceutical industry.
Market Performance and Financials
The company’s stock has experienced notable fluctuations over the past year. The 52-week high was recorded at 284.34 CNH on October 7, 2024, while the 52-week low was 189.9 CNH on September 18, 2024. This range highlights the volatility and investor interest in the company’s stock.
With a market capitalization of 121,360,000,000 CNH, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. remains a substantial entity within the pharmaceutical sector. The company’s price-to-earnings ratio is currently 40.42, indicating investor expectations and market valuation.
Company Overview
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is headquartered in Zhangzhou, China, and specializes in the production and marketing of traditional Chinese medications. The company’s product lineup includes well-known items such as Pientzehuang, Pientzehuang capsules, Pientzehuang lozenges, and cough syrup, among other related products.
Since its Initial Public Offering (IPO) on May 30, 2003, the company has established itself as a key player in the traditional Chinese medicine market. For more information, stakeholders and interested parties can visit the company’s website at www.zzpzh.com .
Conclusion
Zhangzhou Pientzehuang Pharmaceutical Co. Ltd. continues to be a significant entity in the health care sector, particularly within the realm of traditional Chinese medicine. Its recent stock performance and substantial market capitalization underscore its importance and influence in the industry. As the company navigates the dynamic market landscape, it remains a focal point for investors and industry analysts alike.